Portola Pharmaceuticals, Inc.
(NASDAQ : PTLA)

( )
PTLA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
2.80%22.7914.1%$134.10m
MDCOMedicines Company
2.57%55.9920.3%$110.55m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.62%119.126.2%$96.40m
AMRNAmarin Corporation Plc Sponsored ADR
2.12%16.391.8%$87.25m
JAZZJazz Pharmaceuticals Plc
1.14%121.132.3%$62.09m
SAGESAGE Therapeutics, Inc.
2.86%144.838.6%$56.15m
PRGOPerrigo Co. Plc
0.82%54.376.8%$51.78m
PCRXPacira Pharmaceuticals, Inc.
-0.28%38.9210.5%$47.20m
ENDPEndo International Plc
16.11%4.838.8%$41.00m
UTHRUnited Therapeutics Corporation
-0.11%81.6714.3%$37.50m
HZNPHorizon Pharma plc
-0.42%28.486.6%$37.18m
CTLTCatalent Inc
1.88%49.742.4%$35.95m
ICLRICON Plc
-0.07%142.044.1%$34.65m
AERIAerie Pharmaceuticals, Inc.
2.31%21.256.8%$30.50m
ICPTIntercept Pharmaceuticals, Inc.
-0.46%64.4116.9%$30.37m

Company Profile

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. It offers Andexxa, and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.